Additionally, TSL suppressed the proliferation of colon cancer cells via the downregulation of Wnt target genes, such as CCND1 (cyclin D1) and MYC (c-myc) and decreased the cell viability in the MTT assay [119]. The gene discussed is CCND1; the disease is colonic neoplasm.